Intercept Pharmaceuticals, Inc. (ICPT) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
RicElvir RicElvir 12/12/2014 3 months $138.46 $165.76 +19.72% 19 Active
Netteligent Netteligent 10/31/2014 1 month $258.39 $143.73 -44.37% 44 Ended
Waxeng Waxeng 09/02/2014 3 months $287.09 $143.73 -49.94% -49 Ended
Comments: Potential buyout, M/A. and only liver drug w/ great success rate.
Andrew Krishtal Andrew Krishtal 08/12/2014 1 day $299.46 $307.61 +2.72% 2 Ended
danewhy danewhy 05/10/2014 3 months $235.37 $222.79 -5.34% -5 Ended
SmartMoneyMaker2008 SmartMoneyMaker2008 02/11/2014 3 months $361.23 $235.37 -34.84% 34 Ended
Comments: Overvalued, highly speculative with no news to indicate mid-term cashflows
InvestorsXpress InvestorsXpress 01/10/2014 3 months $275.87 $299.30 +8.49% 8 Ended

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.